Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).

Journal of psychiatric practice - 1 Mar 2013

Preskorn Sheldon H, Hatt Cassandra R

Abstract excerpt

This is the first column of a series discussing how advances in pharmacogenomic information (PGI) and molecular biology are leading to changes in the product labels of existing drugs and providing new targets for drug discovery. This column first introduces the concept of PGI and defines related terminology. The authors then discuss how new information on genetic variations in patient responses to drugs has led...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Availability
Share to Biomarkers, Pharmacological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to Drug Monitoring

Share to Drug-Related Side Effects and Adverse Reactions

Share to Pharmaceutical Preparations

Share to Pharmacokinetics

Share to Precision Medicine

Source

Identifiers

PMID: 23507814
DOI: 10.1097/01.pra.0000428559.01953.73

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).PMID 23507814Read ↗

Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care.Semantic proximity Read ↗

Impact of pharmacogenomics on the clinical laboratory.Semantic proximity Read ↗

Pharmacogenomics: An evolving clinical tool for precision medicine.Semantic proximity Read ↗

Pharmacogenetics in clinical practice: how far have we come and where are we going?Semantic proximity Read ↗

Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.Semantic proximity Read ↗

Pharmacogenomics in the clinic.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.Semantic proximity Read ↗

Pharmacogenetics: from discovery to patient care.Semantic proximity Read ↗

Pharmacogenetics: An Important Part of Drug Development with A Focus on Its ApplicationSemantic proximity Read ↗

Clinical pharmacogenomics and concept of personalized medicine / Klinička farmakogenomika i koncept personalizovane medicineSemantic proximity Read ↗

Pharmacogenomics: historical perspective and current status.Semantic proximity Read ↗

Part 1: background, methodology, and clinical adoption of pharmacogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.